Zurich, February 2014
New custom-made media for animal cell culture.
Cell Culture Technologies offers one of the most comprehensive collections of tailor-made culture media worldwide. In addition to over a hundred available custom-made media formulations, this month we introduce a new set of nutrient mixtures to our specialty media collection. Click on the link below to view the updated list of our custom-made culture media.
Cell Culture Technologies Archives
- Production of EVs in customised SteMaxOne medium 10/06/2024
- Culture of tumor cells without carbon dioxide aeration 10/01/2024
- Cell Culture Technologies launches human in vitro nutrition platform 07/09/2023
- Cell Culture Technologies expands its product customisation offering with the launch of 18 new custom media 07/11/2022
- Custom in vitro nutrition for cancer cell research. 19/01/2022
- Making vaccines against COVID with 293 cells ? Test our Hektor S medium ! 12/03/2021
- Principles of in vitro nutrition for human stem cells. 16/07/2020
- Replication of measles virus in chemically defined Hektor and InVitrus VP-6 media. 16/01/2020
- Excellent proliferation of HEK293T cells for the production of retroviral vectors in the chemically defined InVitrus VP-6 medium. 19/06/2019
- Recognized as a leading company in the development and production of custom-made cell culture media, our company now produces over 250 custom media exported to 29 countries worldwide. 06/03/2019
- Cell Culture Technologies inks technical assistance agreements with global health care companies. 11/11/2018
- Customized culture media for translational medicine research. 14/09/2018
- Custom-made culture media made with D-valine instead of L-valine. 27/06/2018
- Cell Culture Technologies celebrates 25th birthday and offers a special discount of 25% on all listed products and services. 04/04/2018
- Cell Culture Technologies launches SteMaxOne™, a chemically defined, protein- and peptide-free culture medium for the maintenance of human mesenchymal stem cells and stem cell lines. 25/08/2017
- Brand new custom-made culture media – We recently added seven new customised media formulations to our specialty media collection as requested by research groups located in Bristol, Copenhagen, Freiburg, Heidelberg, Rotterdam, Perugia and Villigen. 13/04/2017
- StarterKits™ – Serum-free cell lines certified by the European Collection of Authenticated Cell Cultures (ECACC) now available for commercial purposes. 24/01/2017
- Cell Culture Technologies at the Biointerfaces International 2016 Conference and BioTech 2016. 12/01/2017
- Attachment, Growth, and Detachment of Human Mesenchymal Stem Cells in a Chemically Defined Medium from Cell Culture Technologies. 18/08/2016
- ChoMaster®EPO – Investigate the structure of the glycan chains of recombinant human Epo expressed by CHO cells in an open-source minimal medium. 20/01/2016
- Introducing ChoMaster®EPO. 02/09/2015
- Biphasic bioprocess cultivation of alkaline phosphatase-expressing CHO cells in chemically defined, protein- and peptide-free minimal media. 24/11/2014
- Application of custom-made culture media for academic research projects. 15/09/2014
- Case study on the production of recombinant proteins with Sf-9 insect cells in chemically defined, protein- and peptide-free minimal culture media. 11/05/2014
- New custom-made media for animal cell culture. 10/02/2014
- European Research Foundation enters into a technical collaboration with Cell Culture Technologies to cultivate human primary cells in fully synthetic minimal media. 18/11/2013
- Extended batch cultivation of AP-expressing CHO cells by dual medium exchange in fully synthetic ChoMaster® minimal media. 15/09/2013
- A collaboration with NovImmune for the generation of a robust CHO cell-based process platform for generating fully human bispecific monoclonal antibodies in fully synthetic minimal media. 28/04/2013
- Cultivation of Vero cells and replication of measles virus in the fully synthetic InVitrus™ VP-6 minimal culture medium. 10/03/2013
- An outstanding publication in Nature by Alexander Aulehla and his research team at EMBL Heidelberg. 24/02/2013